Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's disease" on page 658.

Gründer, Gerhard; Cumming, Paul (2021). Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's disease" on page 658. Journal of neurochemistry, 156(5), pp. 560-562. Wiley-Blackwell 10.1111/jnc.15269

[img] Text
Journal_of_Neurochemistry_-_2021_-_Gr_nder_-_Serotonin_and_amyloid_deposition_A_link_between_depression_and_Alzheimer_s.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (414kB) | Request a copy

Indirect agonism has been invoked as part of the mechanism of antipsychotic action at dopamine D2/3 receptors, and more recently as a salient neuropharmacological aspect of the serotonin 5-HT2A drug pimavanserin (Pim). We now comment on an article in this volume showing that Pim treatment attenuates the deposition of Aβ protein in brain of transgenic Alzheimer's disease model mice. Pim treatment may interfere with Aβ deposition by shifting the balance between two 5-HT2A signaling pathways, that is, antagonism of Gq/11 signaling and agonism of Gαi1 signaling. Treatment with serotonin-selective reuptake inhibitors (SSRIs) evoked also reduced amyloid deposition in transgenic mice, but SSRI treatment does not unequivocally interfere in the progression of human Alzheimer's disease, perhaps because of complex effects of chronic SSRI treatment on multiple serotonin receptor types. Preclinical findings suggest Pim as a promising pharmacological strategy for intervening against Alzheimer's pathology, perhaps at a very early stage of the disease. However, much remains to be learned about the convergence of various receptor-mediated signaling pathways on the final common path leading to net Aβ deposition.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Cumming, Paul

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0022-3042

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Daria Vogelsang

Date Deposited:

07 Jan 2022 09:57

Last Modified:

07 Jan 2022 10:06

Publisher DOI:

10.1111/jnc.15269

PubMed ID:

33459383

BORIS DOI:

10.48350/162011

URI:

https://boris.unibe.ch/id/eprint/162011

Actions (login required)

Edit item Edit item
Provide Feedback